ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
27.16
-0.10 (-0.37%)
At close: Apr 7, 2026, 4:00 PM EDT
28.48
+1.32 (4.86%)
Pre-market: Apr 8, 2026, 8:51 AM EDT
ARKG Holdings Information
ARKG is an equity ETF with a total of 32 individual holdings. The top holdings are Twist Bioscience stock at 9.45%, CRISPR Therapeutics AG at 9.24%, Tempus AI at 8.84%, 10x Genomics at 6.30%, and Beam Therapeutics at 4.79%.
Total Holdings
32
Top 10 Percentage
59.80%
Asset Class
Equity
ETF Category
Health
Assets
1.06B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 9.45% |
| 2 | CRSP | CRISPR Therapeutics AG | 9.24% |
| 3 | TEM | Tempus AI, Inc. | 8.84% |
| 4 | TXG | 10x Genomics, Inc. | 6.30% |
| 5 | BEAM | Beam Therapeutics Inc. | 4.79% |
| 6 | PSNL | Personalis, Inc. | 4.70% |
| 7 | ILMN | Illumina, Inc. | 4.47% |
| 8 | NTRA | Natera, Inc. | 4.45% |
| 9 | GH | Guardant Health, Inc. | 3.96% |
| 10 | NTLA | Intellia Therapeutics, Inc. | 3.60% |
| 11 | CDNA | CareDx, Inc. | 3.55% |
| 12 | RXRX | Recursion Pharmaceuticals, Inc. | 3.52% |
| 13 | ABSI | Absci Corporation | 3.13% |
| 14 | VCYT | Veracyte, Inc. | 2.89% |
| 15 | ADPT | Adaptive Biotechnologies Corporation | 2.66% |
| 16 | NRIX | Nurix Therapeutics, Inc. | 2.42% |
| 17 | WGS | GeneDx Holdings Corp. | 2.24% |
| 18 | SDGR | Schrödinger, Inc. | 2.15% |
| 19 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.05% |
| 20 | BFLY | Butterfly Network, Inc. | 1.93% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.91% |
| 22 | CMPS | COMPASS Pathways plc | 1.70% |
| 23 | ATAI | AtaiBeckley Inc. | 1.50% |
| 24 | PRME | Prime Medicine, Inc. | 1.47% |
| 25 | PACB | Pacific Biosciences of California, Inc. | 1.39% |
As of Apr 7, 2026